NOVOCODEX
NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.
NOVOCODEX
Industry:
Clinical Trials Health Care Product Research
Founded:
2015-01-01
Status:
Active
Total Funding:
400 M CNY
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Founder
Investors List
Matrix Partners China
Matrix Partners China investment in Series A - NovoCodex
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - NovoCodex
CMG-SDIC Capital Management
CMG-SDIC Capital Management investment in Series A - NovoCodex